Related Experiment Videos
[Recent findings in fetal lung development: structure, surfactant, lung fluid]
1Institut für Pathologische Physiologie der Karl-Marx-Universität, Leipzig.
Zentralblatt Fur Gynakologie
|January 1, 1990
Summary
Fetal lung development involves surfactant production by type II cells, crucial for breathing after birth. Surfactant deficiency can be treated with exogenous preparations, aiding premature infants.
Area of Science:
- Pulmonary Medicine
- Developmental Biology
- Biochemistry
Context:
- Lung development continues postnatally, with alveolarization extending to 8-11 years.
- Epithelial cell differentiation and type II cell identification occur from 24 weeks gestation.
- Fetal lung liquid contributes significantly to amniotic fluid and its secretion is regulated by beta-adrenergic receptors.
Purpose:
- To detail the developmental timeline of fetal lung maturation.
- To explain the hormonal regulation of surfactant synthesis.
- To describe the composition and function of pulmonary surfactant.
Summary:
- Type II alveolar cells synthesize surfactant, a vital phospholipid-protein complex, starting from 24 weeks gestation.
- Surfactant production is influenced by fetal hormones (T3, cortisol, prolactin) and inhibited by insulin and testosterone.
- Adequate surfactant levels are achieved at term, but deficiency can be managed with exogenous treatments.
Impact:
- Understanding fetal lung development is critical for managing premature births and respiratory distress syndrome (RDS).
- Exogenous surfactant therapy improves outcomes for neonates with surfactant deficiency.
- Disruption of the alveolar barrier in pathological conditions allows protein leakage, forming hyaline membranes.